Click on there images to view there full Bios
2021 Program Committee
Brian Alexander M.D., M.P.H.
Foundation Health
David F. Arons JD.
Chief Executive Officer National Brain Tumor Society (NBTS)
Ronald Arthur
American Association of Cancer Research (AACR)
Michele Atlan
President of the Breast Cancer Care & Research Fund (BCCRF)
Sanjeeve Bala
VP, US Regulatory Affairs at BeiGene
Marijo Bilusic, MD
National Cancer Institute
(NCI)
William G. Cance
Chief Medical and Scientific Officer, American Cancer Society
Renzo Canetta, M.D.
Independent Consultant.
Phillip Febbo, MD
Physician Scientist at Illumina
Thomas Fleming, PhD
University of Washington
Julie R. Gralow, MD, FACP, FASCO
CMO American Society of Clinical Oncology (ASCO)
Donald R. Harvey III, PharmD
Emory University
Ke Liu, MD, PhD
SANA Biotech
Patricia Lorusso, D.O.
Associate Director of Innovative Medicine, Yale Cancer Center
Kathryn Lurain, MD
National Cancer Institute (NCI)
Claire Friedman, MD
National Cancer Institute
(NCI)
Elizabeth Mansfield
Vice President of Regulatory Strategy at GRAIL
Lisa Meier McShane, Ph.D.
Associate Director, Division of Cancer Treatment and Diagnosis, NIH
Jon Retzlaff
Chief Policy Officer & Vice President, Science Policy and Government Affairs, AACR
Mace Rothenberg
Board Member at Surrozen
Eric H. Rubin, M.D.
SVP, Clinical Oncology at Merck
Richard L. Schilsky, MD
FACP, FSCT, FASCO, Professor emeritus, University of Chicago
Mary (Dicey) Jackson Scroggins, MA
Director of Global Outreach and Engagement, International Gynecologic Cancer Society
Elad Sharon, MD, MPH
National Cancer Institute
(NCI)
Ishwaria Subbiah, MD
MD Anderson Cancer Center
Laura Van 't Veer
Professor Laboratory Medicine and Director Applied Genomics at the Cancer Center at UCSF
Jaap Verweij, M.D., Ph.D
Managing Director, Cancer Drug Development Forum